Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]-Reference-Cited by-同舟云学术

Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]

Published:2007-03 Issue:3 Volume:65 Page:573-580
ISSN:0278-2391
Container-title:Journal of Oral and Maxillofacial Surgery
language:en
Short-container-title:Journal of Oral and Maxillofacial Surgery

Author:

Harper Richard P.,Fung Eugene

Publisher

Elsevier BV

Subject

Otorhinolaryngology,Oral Surgery,Surgery

Reference50 articles.

1. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic;Marx;J Oral Maxillofac Surg,2003

2. Bisphosphonates and oral cavity avascular bone necrosis;Migliorati;J Clin Oncol,2003

3. Bisphosphonates and avascular necrosis of the jaw;Carter;Aust Dent J,2003

4. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases;Ruggiero;J Oral Maxillofac Surg,2004

5. Osteonecrosis of the maxilla and mandible: Possible drug-induced complication of bisphosphonate therapy;Estilo;Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2004

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we manage medication-related osteonecrosis of the jaw;European Journal of Medical Research;2024-08-02

2. Adjunctive recombinant human parathyroid hormone agents for the treatment of medication-related osteonecrosis of the jaw: a report of three cases;Journal of the Korean Association of Oral and Maxillofacial Surgeons;2024-04-30

3. Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review;Journal of Oral and Maxillofacial Research;2023-12-31

4. Teriparatide-induced alleviation of medication-related osteonecrosis of the jaw: Potential molecular mechanisms;Medical Hypotheses;2023-10

5. Humán rekombináns parathormon (teriparatid) mint alternatív megoldás a gyógyszer okozta állcsontnekrózis terápiájára;Orvosi Hetilap;2023-09-10